Skip to main content
. 2020 Jun 18;27(1):888–899. doi: 10.1080/10717544.2020.1775726

Table 9.

Results of percent cumulative drug permeated from niosomal gel formulation (G2) and marketed formulation in STF of pH 7.4.

Time (hr) Average percent cumulative drug permeated (Mean ± SD, n = 3)
G2 Marketed formulation
0 0 0
1 06.97 ± 1.23 10.95 ± 0.34
2 12.65 ± 0.86 14.15 ± 0.76
3 20.81 ± 1.98 23.97 ± 0.43
4 32.46 ± 1.17 38.64 ± 1.45
5 42.12 ± 0.24 47.71 ± 1.21
6 52.75 ± 1.65 57.94 ± 0.97
7 65.51 ± 0.67 69.29 ± 0.56
8 75.23 ± 1.25 80.47 ± 0.34